REQUEST A DEMO
Total
USD $0.00
Search more companies

Chengdu Kanghong Pharmaceutical Group Co., Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chengdu Kanghong Pharmaceutical Group Co., Ltd Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Chengdu Kanghong Pharmaceutical Group Co., Ltd is a company located in Chengdu, China. The company specializes in the research, development, production, and sales of chemical drugs, traditional Chinese medicine, and biological products. Their products have received various honors and titles, such as "National Key New Product," "National Torch Program Key Project," "Sichuan Famous Brand Product," and "Sichuan Time-Honored Brand." In 2009, the company's "Kanghong" trademark was recognized as a "China Famous Trademark" by the State Administration for Industry and Commerce. They have also been awarded honors like "High-tech Enterprise Certification," "AAA Enterprise Credit Rating," and "Sichuan Province Advanced Unit for Technological Innovation." The company has a national-level enterprise technology center, a national-level postdoctoral research workstation, and a key laboratory in Sichuan Province. They have undertaken ten national-level projects, including one national key basic research and development program (973 Program), three national high-tech research and development programs (863 Program), three national "Major New Drug Creation" science and technology major projects, and other special projects, as well as over 30 provincial and municipal scientific and technological research projects. The company holds 48 invention patents, including 13 international patents.

Headquarters
No. 108, Shuxi Road, Jinniu District, Chengdu, Sichuan Province
Chengdu; Sichuan; Postal Code: 610036

Contact Details: Purchase the Chengdu Kanghong Pharmaceutical Group Co., Ltd report to view the information.

Website: http://www.cnkh.com

Basic Information
Total Employees:
Purchase the Chengdu Kanghong Pharmaceutical Group Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Chengdu Kanghong Pharmaceutical Group Co., Ltd report to view the information.
Registered Capital:
Purchase the Chengdu Kanghong Pharmaceutical Group Co., Ltd report to view the information.
Financial Auditors:
Purchase the Chengdu Kanghong Pharmaceutical Group Co., Ltd report to view the information.
Incorporation Date:
October 03, 1996
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
31.75%
Purchase this report to view the information.
22.58%
Purchase this report to view the information.
8.73%
Purchase this report to view the information.
4.84%
Purchase this report to view the information.
3.55%
Subsidiaries
Beijing Hongjian Medical Equipment Co., Ltd.
Beijing Kanghong Biological Medicine Co., Ltd.
Chengdu Hongji Biotechnology Co., Ltd.
Company Performance
Financial values in the chart are available after Chengdu Kanghong Pharmaceutical Group Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
13.75%
Total operating revenue
13.57%
Operating profit (EBIT)
15.41%
Net Profit (Loss) for the Period
18.22%
Total assets
9.78%
Total equity
11.05%
Operating Profit Margin (ROS)
0.48%
Net Profit Margin
1.07%
Return on Equity (ROE)
0.69%
Quick Ratio
1.27%
Cash Ratio
1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?